The peptide therapy community relies heavily on animal model data when discussing potential applications, but this creates significant gaps in understanding human safety, dosing, and effectiveness
Here are some signs you have PA: Early signs of pernicious anemia Fatigue (many people wake up tired despite getting enough sleep) Shortness of breath Feeling dizzy Loss of appetite Diarrhea or constipation Lightheadedness when standing up or moving around Pale or yellow skin (in people of European ancestry) Heartburn Swollen tongue Long-term signs of pernicious anemia Short-term memory loss Trouble with balance (for example, struggling to put on your pants or socks while youre standing) Burning feeling in your legs or feet that may get worse at night Depression Trouble focusing and confusion Cold hands and feet Hallucinations Eyesight problems Pernicious anemia tongue About 25% of people with pernicious anemia have symptoms on their tongues
PEA has anti-inflammatory effects on the body by inhibiting the production of pro-inflammatory cytokines and by reducing the activity of activated microglia cells
The use of P5091 or P22077, two USP7 inhibitors, display a strong senolytic activity in several models of senescence 31
For a full comparison, the SeekPeptides semaglutide versus tirzepatide comparison page breaks down efficacy, side effects, dosing schedules, and cost considerations
